Who owns ACELRX PHARMACEUTICALS INC?
- Ticker: TLPH
- CUSIP Number: 00444t209
Tip: Access positions for across all investors
Analyze quarterly positions in Acelrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acelrx Pharmaceuticals stock
Who bought or sold ACELRX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 4.5M | $4.0M | 100% | Sep 2025 |
|
| Rosalind Advisors | 4.4M | $3.9M | 119% | Sep 2025 |
|
| Rock Springs Capital Management | 3.6M | $3.2M | 1034% | Sep 2025 |
|
| Nantahala Capital Management | 3.5M | $3.1M | 75% | Sep 2025 |
|
| Bleichroeder | 881k | $787k | 107% | Sep 2025 |
|
| Vanguard Group | 286k | $257k | 252% | Sep 2025 |
|
| Caption Management | 250k | $223k | 100% | Sep 2025 |
|
| Geode Capital Management | 166k | $149k | 0% | Sep 2025 |
|
| Dauntless Investment Group | 100k | $89k | 100% | Sep 2025 |
|
| Values First Advisors | 98k | $87k | -1% | Sep 2025 |
|
| BlackRock | 92k | $82k | 0% | Sep 2025 |
|
| Renaissance Technologies | 50k | $45k | 123% | Sep 2025 |
|
| Virtu Financial | 33k | $29k | 100% | Sep 2025 |
|
| Group One Trading | 30k | $27k | 202667% | Sep 2025 |
|
| UBS Group | 28k | $25k | 125582% | Sep 2025 |
|
| Mariner Wealth Advisors | 25k | $22k | 100% | Sep 2025 |
|
| State Street Corporation | 22k | $20k | 0% | Sep 2025 |
|
| Citadel Advisors | 15k | $14k | 100% | Sep 2025 |
|
| Onyx Bridge Wealth Group | 12k | $10k | 12% | Sep 2025 |
|
| Susquehanna International | 11k | $10k | 100% | Sep 2025 |
|
| Northern Trust | 11k | $9.7k | 0% | Sep 2025 |
|
| PFG Investments | 10k | $8.9k | 100% | Sep 2025 |
|
| Tower Research Capital | 6.2k | $5.5k | 27% | Sep 2025 |
|
| MAI Wealth Advisors | 3.3k | $3.0k | -5% | Sep 2025 |
|
| Sterling Capital Management | 2.0k | $1.8k | 0% | Sep 2025 |
|
| Simplex Trading | 1.2k | $1.0k | 100% | Sep 2025 |
|
| Goss Wealth Management | 500.00 | $447.000000 | 0% | Sep 2025 |
|
| Wells Fargo & Company | 483.00 | $430.980900 | 0% | Sep 2025 |
|
| SBI Securities | 253.00 | $226.004900 | 0% | Sep 2025 |
|
| Silicon Valley Capital Partners | 137.00 | $121.998500 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 136.00 | $120.999200 | 0% | Sep 2025 |
|
| Global Retirement Partners | 73.00 | $64.999200 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 26.00 | $14.001000 | -54% | Sep 2025 |
|
| Dogwood Wealth Management | 10.00 | $9.000000 | 0% | Sep 2025 |
|
| Morgan Stanley | 10.00 | $5.000000 | 100% | Jun 2025 |
|
Who sold out of Acelrx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2025 | 14k | $6.5k |
| Two Sigma Securities | Jun 2025 | 11k | $5.1k |
| GPS Wealth Strategies Group | Jun 2025 | 2.3k | $1.1k |
| Raymond James Financial | Jun 2025 | 145.00 | $67.004500 |
| Jpmorgan Chase & Co | Mar 2025 | 40.00 | $20.000000 |
| CWM | Jun 2025 | 12.00 | $0 |